PL2643004T3 - Kompozycja oligosacharydów do leczenia chorób skóry - Google Patents

Kompozycja oligosacharydów do leczenia chorób skóry

Info

Publication number: PL2643004T3
Authority: PL; Poland
Prior art keywords: skin diseases; treating skin; oligosaccharide composition; oligosaccharide; composition
Prior art date: 2010-11-23

Application number

PL11784693T

Other languages

English (en)

Inventor

Norbert Sprenger

Original Assignee

Nestec S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-11-23

Filing date

2011-11-21

Publication date

2017-07-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43660944&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2643004(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-11-21 Application filed by Nestec S.A. filed Critical Nestec S.A.

2017-07-31 Publication of PL2643004T3 publication Critical patent/PL2643004T3/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Microbiology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Biotechnology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Pediatric Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

PL11784693T 2010-11-23 2011-11-21 Kompozycja oligosacharydów do leczenia chorób skóry PL2643004T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP10192227A EP2465507A1 (en)	2010-11-23	2010-11-23	Oligosaccharide composition for treating skin diseases
EP11784693.1A EP2643004B1 (en)	2010-11-23	2011-11-21	Oligosaccharide composition for treating skin diseases

Publications (1)

Publication Number	Publication Date
PL2643004T3 true PL2643004T3 (pl)	2017-07-31

Family

ID=43660944

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL11784693T PL2643004T3 (pl)	2010-11-23	2011-11-21	Kompozycja oligosacharydów do leczenia chorób skóry

Country Status (18)

Country	Link
US (1)	US8771674B2 (pl)
EP (2)	EP2465507A1 (pl)
CN (1)	CN104302297A (pl)
AU (1)	AU2011340880B2 (pl)
BR (1)	BR112013011730A2 (pl)
CA (1)	CA2818011A1 (pl)
CL (1)	CL2013001436A1 (pl)
ES (1)	ES2616957T3 (pl)
IL (1)	IL226049A0 (pl)
MX (1)	MX341684B (pl)
MY (1)	MY160894A (pl)
PH (1)	PH12013500892B1 (pl)
PL (1)	PL2643004T3 (pl)
RU (1)	RU2609838C2 (pl)
SG (1)	SG190079A1 (pl)
TW (1)	TW201300111A (pl)
WO (1)	WO2012076321A1 (pl)
ZA (1)	ZA201304638B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2454948A1 (en)	2010-11-23	2012-05-23	Nestec S.A.	Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465509A1 (en)	2010-11-23	2012-06-20	Nestec S.A.	Oligosaccharide composition for treating acute respiratory tract infections
PH12013501382A1 (en)	2010-12-31	2013-09-02	Abbott Lab0Ratories	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
CN103379908B (zh)	2010-12-31	2020-02-14	雅培制药有限公司	使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法
MY171851A (en)	2011-06-20	2019-11-04	Heinz Co Brands H J Llc	Probiotic compositions and methods
CA2842672A1 (en)	2011-07-22	2013-01-31	Abbott Laboratories	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY169326A (en)	2011-08-29	2019-03-21	Abbott Lab	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2656862A1 (en) *	2012-04-24	2013-10-30	The Procter & Gamble Company	Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
EP2857410A1 (en)	2013-10-04	2015-04-08	Jennewein Biotechnologie GmbH	Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
US10758555B2 (en) *	2013-11-15	2020-09-01	Societe Des Produits Nestle S.A.	Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
US10568896B2 (en)	2013-11-19	2020-02-25	Abbott Laboratories	Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
WO2015085549A1 (en) *	2013-12-12	2015-06-18	Nestec S.A.	An age-tailored nutrition system for an infant
EP2885977A1 (en) *	2013-12-19	2015-06-24	Agriculture and Food Development Authority (TEAGASC)	An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US10695358B2 (en) *	2013-12-20	2020-06-30	Abbott Laboratories	Oral rehydration composition with oligosaccharides
MX2016013064A (es)	2014-04-08	2017-01-26	Abbott Lab	Metodos para mejorar las respuestas inmune innata y/o deteccion de patogenos de la mucosa mediante oligosacaridos de la leche humana.
CA2954662C (en)	2014-07-09	2024-03-19	Midori Usa, Inc.	Oligosaccharide compositions and methods for producing thereof
DK3209308T3 (da) *	2014-10-24	2022-10-03	Evolve Biosystems Inc	Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
EP4209130A1 (en)	2015-01-26	2023-07-12	DSM Nutritional Products, LLC	Oligosaccharide compositions for use animal feed and methods of producing thereof
EP4508990A2 (en) *	2015-03-05	2025-02-19	Société des Produits Nestlé S.A.	Compositions for use in improving stool consistency or frequency in infants or young children
US20180147221A1 (en)	2015-04-23	2018-05-31	Kaleido Biosciences, Inc.	Glycan therapeutic compositions and related methods thereof
US10034937B2 (en)	2015-12-04	2018-07-31	Mead Johnson Nutrition Company	Synergistic nutritional compositions and uses thereof
EP3407739B1 (en) *	2016-01-26	2021-06-23	Société des Produits Nestlé S.A.	Composition for use in the prevention and/or treatment of skin conditions and skin diseases
AU2017240069B2 (en)	2016-03-31	2024-03-07	Gojo Industries, Inc.	Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240068B2 (en)	2016-03-31	2022-12-15	Gojo Industries, Inc.	Antimicrobial peptide stimulating cleansing composition
JP2020500860A (ja)	2016-11-23	2020-01-16	ゴジョ・インダストリーズ・インコーポレイテッド	プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
WO2019038668A1 (en)	2017-08-21	2019-02-28	Glycom A/S	SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP3784268A4 (en) *	2018-04-25	2022-04-27	Health and Happiness (H&H) Hong Kong Limited	COMBINATIONS OF OSTEOPONTIN AND 2'-FUCOSYLLACTOSE FOR USE AS MEDICINES
SG11202011188SA (en) *	2018-05-11	2020-12-30	Forte Subsidiary Inc	Compositions for the treatment of skin conditions
CN108935697A (zh) *	2018-09-11	2018-12-07	内蒙古伊利实业集团股份有限公司	一种用于预防小儿湿疹的营养组合物
US20220022515A1 (en)	2019-02-25	2022-01-27	Nutribam Bv	Composition, Food Supplement and Method for Supporting and/or Improving Intestinal Health
BE1027078A9 (nl) *	2019-02-25	2020-09-28	Nutribam Bvba	Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
ES1240969Y (es) *	2019-09-18	2020-07-30	Jennewein Biotechnologie Gmbh	Composiciones de cereales que contienen oligosacaridos de la leche humana

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0481038B1 (en)	1990-04-16	2002-10-02	The Trustees Of The University Of Pennsylvania	Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en)	1994-09-26	1996-08-13	The Rockefeller University	Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
DE602004017885D1 (de) *	2003-10-24	2009-01-02	Nutricia Nv	Symbiotische zusammensetzung für kleinkinder
WO2005055944A2 (en) *	2003-12-05	2005-06-23	Cincinnati Children's Hospital Medical Center	Oligosaccharide compositions and use thereof in the treatment of infection
EP1634599A1 (en) *	2004-08-20	2006-03-15	N.V. Nutricia	Iimmune stimulatory infant nutrition
CA2614111A1 (en) *	2005-06-24	2006-12-28	Calpis Co., Ltd.	Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
PL1993576T3 (pl) *	2006-03-07	2016-04-29	Nestec Sa	Mieszanina synbiotyczna
CN103315205A (zh) *	2006-03-10	2013-09-25	纽崔西亚公司	不可消化的糖用于在出生后给予婴儿最佳开始的用途
WO2007114683A1 (en) *	2006-03-30	2007-10-11	N.V. Nutricia	Milk oligosaccharides for stimulating the immune system
EP1974743A1 (en) *	2007-03-28	2008-10-01	Nestec S.A.	Probiotics to Improve Gut Microbiota
EP2127661A1 (en) *	2008-05-27	2009-12-02	Nestec S.A.	Probiotics to improve gut microbiotica
WO2010002241A1 (en) *	2008-06-30	2010-01-07	N.V. Nutricia	Nutritional composition for infants delivered via caesarean section

2010
- 2010-11-23 EP EP10192227A patent/EP2465507A1/en not_active Withdrawn
2011
- 2011-11-21 ES ES11784693.1T patent/ES2616957T3/es active Active
- 2011-11-21 SG SG2013033345A patent/SG190079A1/en unknown
- 2011-11-21 EP EP11784693.1A patent/EP2643004B1/en active Active
- 2011-11-21 PL PL11784693T patent/PL2643004T3/pl unknown
- 2011-11-21 CA CA2818011A patent/CA2818011A1/en not_active Abandoned
- 2011-11-21 RU RU2013128594A patent/RU2609838C2/ru active
- 2011-11-21 MX MX2013005725A patent/MX341684B/es active IP Right Grant
- 2011-11-21 WO PCT/EP2011/070561 patent/WO2012076321A1/en active Application Filing
- 2011-11-21 AU AU2011340880A patent/AU2011340880B2/en active Active
- 2011-11-21 US US13/988,990 patent/US8771674B2/en active Active
- 2011-11-21 PH PH1/2013/500892A patent/PH12013500892B1/en unknown
- 2011-11-21 BR BR112013011730A patent/BR112013011730A2/pt not_active IP Right Cessation
- 2011-11-21 MY MYPI2013700678A patent/MY160894A/en unknown
- 2011-11-21 CN CN201180056411.7A patent/CN104302297A/zh active Pending
- 2011-11-23 TW TW100142958A patent/TW201300111A/zh unknown
2013
- 2013-04-29 IL IL226049A patent/IL226049A0/en unknown
- 2013-05-17 CL CL2013001436A patent/CL2013001436A1/es unknown
- 2013-06-21 ZA ZA2013/04638A patent/ZA201304638B/en unknown

Also Published As

Publication number	Publication date
ES2616957T3 (es)	2017-06-14
US20130251682A1 (en)	2013-09-26
AU2011340880B2 (en)	2017-03-02
EP2465507A1 (en)	2012-06-20
CN104302297A (zh)	2015-01-21
CA2818011A1 (en)	2012-06-14
MX341684B (es)	2016-08-30
MY160894A (en)	2017-03-31
PH12013500892A1 (en)	2013-07-01
CL2013001436A1 (es)	2014-02-14
EP2643004B1 (en)	2016-12-21
AU2011340880A1 (en)	2013-05-23
US8771674B2 (en)	2014-07-08
EP2643004A1 (en)	2013-10-02
MX2013005725A (es)	2013-07-03
PH12013500892B1 (en)	2017-12-15
IL226049A0 (en)	2013-06-27
RU2609838C2 (ru)	2017-02-06
RU2013128594A (ru)	2014-12-27
BR112013011730A2 (pt)	2016-08-16
SG190079A1 (en)	2013-06-28
WO2012076321A1 (en)	2012-06-14
TW201300111A (zh)	2013-01-01
ZA201304638B (en)	2016-02-24

Publication	Publication Date	Title
PL2643004T3 (pl)	2017-07-31	Kompozycja oligosacharydów do leczenia chorób skóry
IL260585B (en)	2019-08-29	Preparations and methods for the treatment of diseases related to the retina of the eye
EP2655334A4 (en)	2014-12-31	COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
IL226127A0 (en)	2013-06-27	A compound containing hydrolyzed proteins and an oligosaccharide for the treatment of skin diseases
ZA201208413B (en)	2014-01-29	Skin treatment composition
ZA201308417B (en)	2014-07-30	Tissue healing
IL212793A0 (en)	2011-07-31	Handpiece for treating skin
EP2654745A4 (en)	2014-03-26	COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
HK1178465A1 (en)	2013-09-13	Composition for improving condition of skin
ZA201301601B (en)	2018-12-19	Treatment of diseases
EP2613786A4 (en)	2013-10-23	TREATMENT OF DISEASES
EP2544655A4 (en)	2014-05-14	COMPOSITIONS AND METHODS FOR TREATING SKIN
EP2621498A4 (en)	2014-04-09	COMBINED TREATMENT OF DERMATOLOGICAL CONDITIONS
PL2539352T3 (pl)	2018-03-30	Pochodne amp do leczenia chorób serca
IL214133A0 (en)	2011-08-31	Skin treatment
GB0902040D0 (en)	2009-03-11	Composition for treatment of skin
EP2797593A4 (en)	2014-12-17	SILICONE-BASED COMPOSITION FOR TREATING SKIN
EP2659879A4 (en)	2014-12-10	HAIR TREATMENT AGENT COMPOSITION
EP2709632A4 (en)	2015-03-04	COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
ZA201301458B (en)	2014-06-25	Therapeutic agent for pain
HK1161510A2 (en)	2012-07-27	A composition for treating skin diseases
EP2593111A4 (en)	2014-07-23	NEW COMPOUNDS FOR THE TREATMENT OF CANCER AND OTHER DISEASES
EP2601954A4 (en)	2014-02-26	THERAPEUTIC FOR DISEASES
ZA201208568B (en)	2014-01-29	Skin treatment composition
WO2013003465A9 (en)	2013-03-28	Methods and compositions for treating skin